SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-023233
Filing Date
2022-11-08
Accepted
2022-11-08 16:17:11
Documents
58
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q asmb-20220930.htm   iXBRL 10-Q 2734347
2 EX-31.1 asmb-ex31_1.htm EX-31.1 22553
3 EX-31.2 asmb-ex31_2.htm EX-31.2 22516
4 EX-32.1 asmb-ex32_1.htm EX-32.1 12763
5 EX-32.2 asmb-ex32_2.htm EX-32.2 12743
  Complete submission text file 0000950170-22-023233.txt   9070249

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asmb-20220930_pre.xml EX-101.PRE 279261
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asmb-20220930_lab.xml EX-101.LAB 367146
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT asmb-20220930_def.xml EX-101.DEF 165270
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT asmb-20220930_cal.xml EX-101.CAL 40850
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asmb-20220930.xsd EX-101.SCH 43518
52 EXTRACTED XBRL INSTANCE DOCUMENT asmb-20220930_htm.xml XML 1966882
Mailing Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35005 | Film No.: 221369143
SIC: 2834 Pharmaceutical Preparations